The maker of Ozempic is slashing prices for U.S. patients who pay cash, a major shift in the fast-growing market for the drug.
U.S.

Ozempic to cost much less for cash customers

1:39

The maker of Ozempic is slashing prices for U.S. patients who pay cash, a major shift in the fast-growing market for the drug.

Go to story →

Related Stories

Unbiased Updates